Product Information
EVEROLIMUS 1 MG TABLET is a generic product labeled by Breckenridge Pharmaceutical Inc., priced at $6.7564 per EA under NDC 51991098506. Its NADAC has been published 32 times since Nov 19, 2025.
Strength
1 mg/1
Manufacturer
Breckenridge Pharmaceutical Inc.NDC
51991098506
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
EVEROLIMUSApproval Type
Generic (ANDA)
FDA Application
ANDA205432On Market Since
10/30/2025
Pharmacological Classes
Price Statistics
The NADAC for EVEROLIMUS 1 MG TABLET has been published 32 times since Nov 19, 2025, and over the history we have for it it has declined 52.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $6.7564 per EA |
|---|---|
| All-time high | $14.1397 (Dec 10, 2025) |
| All-time low | $6.7564 (Jun 17, 2026) |
| 52-week high | $14.1397 |
| 52-week low | $6.7564 |
| Median price | $9.8453 |
| Average price | $10.0506 |
| Largest weekly change | -12.3% (Dec 17, 2025) |
| Weeks tracked | 32 |
| Tracking since | Nov 19, 2025 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the Everolimus tablets market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of EVEROLIMUS 1 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for EVEROLIMUS 1 MG TABLET, manufactured by Breckenridge Pharmaceutical Inc., is $6.7564 per EA (NDC 51991098506), effective Jun 24, 2026.
How has the price of EVEROLIMUS 1 MG TABLET changed over time?
Over the history we have for it, the NADAC for EVEROLIMUS 1 MG TABLET has declined 52.2%. It has been tracked across 32 weekly CMS publications since Nov 19, 2025.
What are the highest and lowest recorded NADAC prices for EVEROLIMUS 1 MG TABLET?
Since Nov 19, 2025, the NADAC for EVEROLIMUS 1 MG TABLET has ranged from a low of $6.7564 (Jun 17, 2026) to a high of $14.1397 (Dec 10, 2025), with a median of $9.8453 per EA.
Are there cheaper alternatives to EVEROLIMUS 1 MG TABLET?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of EVEROLIMUS 1 MG TABLET, so no direct lower-cost alternative is listed.
Who manufactures EVEROLIMUS 1 MG TABLET?
EVEROLIMUS 1 MG TABLET (NDC 51991098506) is labeled by Breckenridge Pharmaceutical Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification